CSIMarket
 


Paratek Pharmaceuticals Inc   (PRTK)
Other Ticker:  
 
 

PRTK's Capital Expenditures Growth by Quarter and Year

Paratek Pharmaceuticals Inc 's Capital Expenditures results by quarter and year




PRTK Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.00 0.00 0.05
III Quarter September - 0.00 0.00 0.04
II Quarter June - 0.00 0.12 0.04
I Quarter March 0.03 0.04 0.26 0.25
FY   0.03 0.04 0.38 0.38



PRTK Capital Expenditures first quarter 2023 Y/Y Growth Comment
Paratek Pharmaceuticals Inc reported decline in Capital Expenditures in the first quarter 2023 by -20% to $ 0.03 millions, from the same quarter in 2022.
The contraction in the first quarter 2023 Paratek Pharmaceuticals Inc 's Capital Expenditures compares unfavorably to the Company's average Capital Expenditures doubling of 246.68%.

Looking into first quarter 2023 results within Major Pharmaceutical Preparations industry 161 other companies have achieved higher Capital Expenditures growth. While Paratek Pharmaceuticals Inc ' s Capital Expenditures fall of -20% ranks overall at the positon no. 2541 in the first quarter 2023.




PRTK Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -73.68 %
III Quarter September - - - 33.33 %
II Quarter June - - 200 % -
I Quarter March -20 % -84.62 % 4 % 2400 %
FY   - -89.47 % 0 % 65.22 %

Financial Statements
Paratek Pharmaceuticals Inc 's first quarter 2023 Capital Expenditures $ 0.03 millions PRTK's Income Statement
Paratek Pharmaceuticals Inc 's first quarter 2022 Capital Expenditures $ 0.04 millions Quarterly PRTK's Income Statement
New: More PRTK's historic Capital Expenditures Growth >>


PRTK Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - 25 %
III Quarter September - - - 0 %
II Quarter June - - -53.85 % -84 %
I Quarter March - - 420 % 31.58 %
FY (Year on Year)   - -89.47 % 0 % 65.22 %




Capital Expenditures first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #162
Healthcare Sector #404
Overall #2541

Capital Expenditures Y/Y Growth Statistics
High Average Low
3133.33 % 246.68 % -100 %
(Dec 31 2019)   (Jun 30 2022)
Capital Expenditures first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #162
Healthcare Sector #404
Overall #2541
Capital Expenditures Y/Y Growth Statistics
High Average Low
3133.33 % 246.68 % -100 %
(Dec 31 2019)   (Jun 30 2022)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Paratek Pharmaceuticals Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRTK's I. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRTK's I. Quarter Q/Q Capital Expenditures Comment


Paratek Pharmaceuticals Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Mar 31 2023 period, Paratek Pharmaceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Paratek Pharmaceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Mar 31 2023 period, Paratek Pharmaceuticals Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Paratek Pharmaceuticals Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
PRTK's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for PRTK's Competitors
Capital Expenditures Growth for Paratek Pharmaceuticals Inc 's Suppliers
Capital Expenditures Growth for PRTK's Customers

You may also want to know
PRTK's Annual Growth Rates PRTK's Profitability Ratios PRTK's Asset Turnover Ratio PRTK's Dividend Growth
PRTK's Roe PRTK's Valuation Ratios PRTK's Financial Strength Ratios PRTK's Dividend Payout Ratio
PRTK's Roa PRTK's Inventory Turnover Ratio PRTK's Growth Rates PRTK's Dividend Comparisons



Companies with similar Capital Expenditures fall for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2023
Treace Medical Concepts Inc -0.20%$ -0.203 millions
Surgalign Holdings Inc -0.75%$ -0.745 millions
Pediatrix Medical Group Inc -2.04%$ -2.043 millions
Rani Therapeutics Holdings Inc -2.36%$ -2.362 millions
Repare Therapeutics Inc -2.46%$ -2.464 millions
Longeveron Inc -2.54%$ -2.542 millions
Sonida Senior Living Inc -2.74%$ -2.741 millions
Organovo Holdings Inc -3.18%$ -3.178 millions
The Pennant Group Inc -3.26%$ -3.261 millions
Psychemedics Corp-4.65%$ -4.651 millions
Adaptive Biotechnologies Corporation-4.97%$ -4.972 millions
Dynavax Technologies Corporation-5.52%$ -5.523 millions
Idexx Laboratories Inc-5.56%$ -5.562 millions
Xtant Medical Holdings Inc -5.79%$ -5.785 millions
Ufp Technologies Inc -6.64%$ -6.641 millions
Revolution Medicines Inc -6.93%$ -6.935 millions
Skye Bioscience Inc -6.95%$ -6.953 millions
Biocept Inc -7.14%$ -7.143 millions
Invacare Holdings Corporation-7.18%$ -7.180 millions
Neoleukin Therapeutics Inc -7.30%$ -7.301 millions
Iqvia Holdings Inc -7.34%$ -7.345 millions
Zimvie Inc -7.82%$ -7.816 millions
Vaxart Inc -7.95%$ -7.949 millions
Urogen Pharma Ltd -8.00%$ -8.000 millions
Boston Scientific Corporation-8.26%$ -8.264 millions
Myomo Inc -9.61%$ -9.611 millions
Jasper Therapeutics Inc -10.34%$ -10.345 millions
Bausch Health Companies Inc -10.53%$ -10.526 millions
Airsculpt Technologies Inc -10.74%$ -10.739 millions
Paratek Pharmaceuticals Inc -11.11%$ -11.111 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com